CJC-1295 no DAC + Ipamorelin: A Research Overview of the Dual-Pathway Growth Hormone Combination

What Is CJC-1295 no DAC + Ipamorelin? CJC-1295 no DAC (also known as Modified GRF 1-29) and Ipamorelin are two synthetic research compounds that are frequently studied in combination due to their complementary mechanisms of action on the growth hormone (GH) axis. CJC-1295 no DAC is a modified analogue of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, they represent one of the most widely investigated compou

← Back to all articles

Peptidex — Research Grade Compounds UK. All products are for laboratory and scientific research use only. Not for human consumption.